Trisalus Life Sciences Inc (TLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 29,431 | 18,511 | 12,398 | 0 | 0 |
| Cost of Goods | 4,103 | 2,605 | 2,258 | N/A | N/A |
| Gross Profit | 25,328 | 15,906 | 10,140 | N/A | N/A |
| Operating Expenses | 61,596 | 70,986 | 46,837 | 3,041 | 109 |
| Operating Income | -36,165 | -54,475 | -36,439 | -3,041 | -109 |
| Interest Expense | 3,090 | 16 | 1 | 0 | 0 |
| Other Income | 9,216 | -4,863 | -10,738 | 7,808 | -603 |
| Pre-tax Income | -30,039 | -59,354 | -47,178 | 4,767 | -711 |
| Income Tax | 6 | 9 | 9 | N/A | N/A |
| Net Income Continuous | -30,045 | -59,363 | -47,187 | 4,767 | -711 |
| Net Income | $-30,045 | $-59,363 | $-47,187 | $4,767 | $-711 |
| EPS Basic Total Ops | -1.31 | -6.77 | -161.55 | 0.15 | -0.12 |
| EPS Basic Continuous Ops | -1.19 | -6.32 | -152.22 | 0.76 | -0.11 |
| EPS Diluted Total Ops | -1.31 | -6.77 | -161.55 | 0.15 | -0.12 |
| EPS Diluted Continuous Ops | -1.19 | -6.32 | -152.22 | 0.76 | -0.11 |
| EPS Diluted Before Non-Recurring Items | -1.48 | -6.73 | N/A | N/A | N/A |
| EBITDA(a) | $-34,809 | $-53,791 | $-36,041 | $-3,041 | $-109 |